| Biotechnology Industry | Healthcare Sector | Ms. Qun Lin CEO | SSE Exchange | CNE1000022T4 ISIN |
| CN Country | 295 Employees | 15 Jul 2025 Last Dividend | 5 May 2016 Last Split | - IPO Date |
Shanghai Hile Bio-Technology Co., Ltd., founded in 1981 and headquartered in Shanghai, China, specializes in the research, development, production, and sale of veterinary biological products. The company focuses on livestock and poultry, providing a comprehensive portfolio of vaccines to address various diseases and conditions. The dedication to innovation and quality has established Shanghai Hile Bio-Technology as a significant player in the veterinary pharmaceutical industry within China.
The company's product line is designed to meet the diverse needs of poultry and livestock health management. Below is a detailed breakdown of their offerings: